STAMFORD, Conn., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
STAMFORD, Conn., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
STAMFORD, Conn., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
STAMFORD, Conn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
STAMFORD, Conn., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical...
As filed with the Securities and Exchange Commission on August 9, 2018 Registration...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.